Gilead Sciences Seeks Marketing Authorisation from India for Potential Covid-19 Drug Remdesivir

Friday 29 May 2020

Gilead Sciences Seeks Marketing Authorisation from India for Potential Covid-19 Drug Remdesivir

in published on May 29, 2020 leave a reply
This comes in the backdrop of two Indian pharmaceutical companies -- Cipla and Hetero Labs -- applying to the drug regulator seeking permission to manufacture and sell remdesivir in India.

from Top Business News- News18.com https://ift.tt/3cb6mFS
Previous Post
Next Post
Rohit

post written by:

0 comments: